FMC Stock - Metzler downgrade puts 200-day line under pressure

FMC stock is trading around a key technical level on Xetra after a downgrade by Metzler Bank. The dialysis provider now faces renewed chart headwinds while investors assess sector conditions and valuation ahead of the next earnings update.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 18:45 CET. Details in the imprint.

FMC (DE0005785802) is back under chart scrutiny on Friday after a fresh analyst move. The dialysis provider's stock is hovering around its simple 200-day moving average after Metzler Bank downgraded the name, according to a dpa-AFX report on MarketScreener.

Metzler's downgrade and reaction

According to the dpa-AFX summary, Metzler Bank cut its rating on FMC and this triggered selling pressure, with shares down about 2.6% in early Frankfurt trading on Friday and briefly below the simple 200-day moving average at EUR 40.20.

The report also cited a previous closing price of EUR 41.26 and an average analyst target price of around EUR 43.38, underlining that sentiment had been cautiously constructive before the downgrade.

Sector comparison on a busy week

Within the European health care sector, FMC's move on Friday looks slightly softer than some diversified peers, as broader market indices traded mixed after a positive week for the Standard & Poor's 500 index and other benchmarks earlier.

Against this backdrop, the downgrade gives FMC shares a stock-specific driver, while many sector names are still trading more on macro news and yields than on individual company headlines.

How Fresenius Medical Care earns money

Fresenius Medical Care's core business is chronic kidney failure treatment, operating dialysis clinics worldwide and supplying equipment such as hemodialysis machines and dialyzers, with recurring revenue streams from long-term patient care and related services.

Where the stock trades today

The shares of Fresenius Medical Care (DE0005785802) trade on Xetra at EUR 40.20 as of 06/19/2026, 12:41 CET.

Fresenius Medical Care at a glance

• Company: Fresenius Medical Care AG
• ISIN: DE0005785802
• WKN: 578580
• Ticker: FME
• Venue: Xetra
• Price (as of 06/19/2026, 12:41 CET): 40.20 EUR
• Market cap: 12,000,000,000 EUR (as of 06/19/2026)
• Sector / Industry: Health Care - Health Care Providers & Services
• Index membership: DAX
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.